Azafaros
ID: 7642895Developer of therapeutics for rare lysosomal storage disorders.
2
Funding Rounds
$174.5m
Money raised
Recent Funding Rounds
Overview
Developer of therapeutics for rare lysosomal storage disorders.
- Website:
- Headquarters: Naarden
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Azafaros has raised a total of $174.5m in funding over 2 rounds.
Key Insights:
- Azafaros Series B Round, May 2025: $147m
- Azafaros , February 2020: $27.5m
Industries
Azafaros is active in the following industries: